ÂÜÀòÂÒÂ×

Carl Chan is a professional with extensive experience in growth equity, currently serving at Thoma Bravo, a prominent private equity firm since 2013. Chan has led significant investments across multiple technology companies, including a $123 million Series E at Alation and $420 million investment at project44. Additional notable investments include leadership roles in Series C and D rounds for companies such as AppOmni, Imply, and Paradox. Chan holds an MBA from The Wharton School and a Bachelor of Commerce in Finance from the University of Calgary.